Skip to content

Guided Poster Tour

Here you can find all the abstracts, presented at the Guided Poster Tour taking place on Thursday, 19.11.2026 from 17h30 - 19h00, Hall 4.0 (close to the session rooms)

Guided Poster Tour Station 1 - Hemostasis, transfusion medicine, vascular, laboratory medicine, benign hematology

Chairs: Patrick Bättig (Basel), Thomas Lehmann (St. Gallen)

  1. Fibrinogen variants, but not common FXIII or fibrinogen polymorphisms, influence clot permeability in hereditary dysfibrinogenaemia - A. Couzens, R. Marchi, T. Simurda, L. Ardillon, C. Biron Andreani, M. Daniel, E. De Maistre, N. Drillaud, B. Frotscher, A. Vega, A. Lebreton, M. Neerman-Arbez, A. Casini
  2. Longitudinal Changes in Lymphocyte Subsets in Donors After Leukapheresis for Donor Lymphocyte Infusion: A Retrospective Swiss Cohort Study - M. Bürgin, K. Frei, J. Lansel, M. Florova, G. Tayfun, D. Schneidawind, S. Waldvogel, A. Holbro, L. Infanti, A. Buser, J. Passweg, G. Nair, J. Lötscher
  3. Uncontrolled thrombin generation drives purpura fulminans in protein S deficiency - M. Tripodo, R. Prince-Eladnani, S. Calzavarini, M. D. Reina Caro, J. A. Fernández, J. H. Griffin, A. Angelillo-Scherrer
  4. Usefulness and performance of procoagulant platelet flow cytometry and multiple electrode aggregometry for detecting platelet-activating HIT antibodies - L. Hayenga, F. J. Gomez, E. Matthey-Guirao, M. G. Zermatten, L. Alberio, A. Aliotta
  5. Newly detected red cell alloantibodies in pregnancy: anti-D, -c or -K were found in only one in five women but accounted for all severe cases - D. Y. Duygu Yildiz Özkaya, P. R. Piet-Lennart Rosenstock, M. D. Michael Daskalakis, K. J. Jalowiec
  6. Lupus Anticoagulant–Hypoprothrombinemia Syndrome: A laboratory diagnostic approach and frequency in 2499 patients - A. Aliotta, E. Matthey-Guirao, F. J. Gomez, L. Alberio, M. G. Zermatten
  7. Effects of Dual Pathway Inhibition on blood clot properties. - A. Casini, M. Lavergne, S. Nolli, J.-L. Reny, P. Fontana
  8. Inter-individual variability of haemostatic correction in patients receiving emicizumab: Bleeding risk and implications for treatment monitoring. - F. Monnin-Respen, A. P. Batista Mesquita Sauvage, F. J. Gomez, C. Pereira Portela, A. Aliotta, L. A. Gautier, D. Shehwar, K. Haeri, M. G. Zermatten, L. Alberio, D. Bertaggia Calderara
  9. Immunoassay Discordance in Heparin-Induced Thrombocytopenia Confirmed by Platelet-activation Assay: a 12-Year Retrospective Review - R. Nieves-Ortega, A. Aliotta, M. G. Zermatten, L. Alberio
  10. Bivalirudin in heparin-induced thrombocytopenia: An analysis of 515 treatment days in 22 patients - T. Veyron, A. Valentin, E. Matthey-Guirao, F. J. Gomez, A. Aliotta, L. Alberio, M. G. Zermatten
  11. In vivo pharmacological effects of apixaban and edoxaban in patients with liver cirrhosis - L. A. Gautier, C. Pereira Portela, D. Bertaggia Calderara, L. Veuthey, A. Aliotta, M. G. Zermatten, E. Mdawar-Bailly, S. Cuénoud, D. Moradpour, M. Fraga, L. Alberio
  12. Predicting the need for a second collection day in allogeneic peripheral blood stem cell donation - M. Baldenweg, E. Mathier, A. Bachofner, P. Hockl, D. Schneidawind, T. Benoit
  13. Recurrent venous thromboembolism in patients with hereditary and acquired thrombophilia after discontinuing anticoagulation – a systematic review and meta-analysis - K. Vrotniakaite-Bajerciene, T.-F. Wang, E. Sabri, A. Angelillo-Scherrer, G. Le Gal, M. Carrier

Poster only (without presentation)

  1. The Swiss Red Blood Cell Disease Registry (RBCR) – an Introduction - N. Dietliker, T. Benoit, R. Kasteler-Amrein, M. Schmugge, E. Picotti
  2. Incidence of thrombosis and bleeding in patients with JAK2 V617F - positive myeloproliferative neoplasms receiving low-dose aspirin – a systematic review and meta-analysis - K. Vrotniakaite-Bajerciene, C. E. Marx, T. Tritschler, R. Shorr, M. Carrier, D. E. Fergusson, A. Delluc, M. Kimpton
  3. Daratumumab for refractory acquired hemophilia A - J.-D. Studt, A. Trinchero
  4. Elevated von Willebrand factor in patients with unexplained coronary stent thrombosis: A retrospective observational study and proposed diagnostic approach - N. Friedrich, N. Dewarrat, F. Grandoni, G. Stalder, L. Alberio
  5. Novel Compound Heterozygous SPTA1 Variants (c.154_159del/αLELY) Causing Severe Hereditary Red Cell Membrane Disorder in Two Brothers - M. Lork, D. Schmidt, M. Grobler, M. Schmugge, M. Amrein
  6. Stress-associated HbF reactivation after allogeneic haematopoietic cell transplantation in a patient with β⁺-thalassaemia trait - M. S. Bader, A. Stelmes, E. Antonopoulou, J. P. Halter, J. R. Passweg, P. Bättig, C. C. Widmer
  7. Clinico-serological positivity preceding laboratory functional conversion in heparin-induced thrombocytopenia: a case series - M. P. Gossin, L. Hayenga, E. Matthey-Guirao, F. J. Gomez, L. Alberio, A. Aliotta, M. G. Zermatten
  8. Evaluation of the AmiCORE Apheresis System for Platelet Apheresis at a regular Blood Transfusion Service - I. Giataganzidou, I. Schmid, J. Wendler, E. Schindler, D. A. Tsakiris
  9. Diagnosis and therapy of congenital TTP in pregnancy and discovery of a new mutation in ADAMTS13 - V. Wester, A. Holbro, N. D. Bui, J. Benz, J. A. Kremer Hovinga, J. van den Berg, N. Schmidlin, P. Bättig, O. Lapaire, N. R. Rusca, G. T. Stehle
  10. Acquired Hemophilia A Associated With Multicentric Castleman Disease: A Case Report and Review of the Literature - T. Gerardi, M. Iarossi, A. Casini, P. Fontana
  11. A double-hit model of neonatal bleeding: fetal and neonatal alloimmune thrombocytopenia associated with severe haemophilia A. - P. Stakia, S. Waldvogel-Abramowski
  12. Uncommon mutation in dehydrated stomatocytosis - N. Dewarrat, J. Walker, J. Schoumans, M. Gavillet
  13. From T-ALL to AML: Immunophenotypic Evolution and Contribution of Flow Cytometry after Haploidentical Transplantation - S. Ennouhi, M. Oubeche, N. Waal, H. Chaouki, L. Enneffah, Y. Khayar, A. Belmekki

Guided Poster Tour Station 2 - Clinical hemato-oncology

Chairs: Justine Epiney (Lausanne), Felicitas Hitz (Münsterlingen)

  1. Serum Immunoglobulin Changes in Multiple Myeloma Patients Treated with CAR T-Cell Therapy - A. Burger, U. Bacher, M. Hoffmann, M. Bertschinger, K. Seipel, C. Schild, I. Shafarostova, T. Pabst
  2. Lower stem-cell yields after daratumumab-VRD induction in a predominantly vinorelbine-mobilised multiple myeloma cohort - A. Genthon, J. Dereme, E. E. Kampouri, E. Gagliarducci, A. Cairoli, M. Nabergoj, S. Barelli, J. Schoumans, N. Lauriers, P.-Y. Bochud, N. Rufer, H. Auner
  3. Donor-Derived Cytogenetic Alterations After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Single-Center Cohort Study - R. Rasiah, S. Kathirchelvan, J. Passweg, J. Halter, M. Stoikou, B. C. Glaeser, S. Cichon, D. Juskevicius, F. Wenzel, C. C. Widmer
  4. Determinants and clinical impact of Hemophagocytic Lymphohistiocytosis in Acute Myeloid Leukemia patients - M. Gavillet, A. Guillet, S. Bibert, M. Nabergoj, E. Kampouri, S. Blum, P.-Y. Bochud
  5. Direct Oral Anticoagulants versus Aspirin for Thromboprophylaxis in Multiple Myeloma Patients Receiving Immunomodulatory Therapy: An Updated Systematic Review and Meta-Analysis - P. Barrera, R. Adhikari, R. Zahid
  6. Earlier Cytokine Release Syndrome Onset Is Associated With Greater Longitudinal Cumulative Chimeric Antigen Receptor T-Cell Expansion After Tisagenlecleucel - D. Meier, G. Wiedemann, J. Rossel, U. Bacher, T. Pabst, I. Chanias, B. Lüscher, A. Angelillo-Scherer, M. Daskalakis, K. Jalowiec
  7. Efficacy and Safety of Venetoclax Bridging Therapy Prior to CAR T-Cell Therapy in Patients with t(11;14) Multiple Myeloma - N. Hodel, M. Bertschinger, M. Hoffmann, I. Shafarostova, U. Bacher, T. Pabst
  8. Single-cell deterministic multimodal interconnected RNA-sequencing and imaging reveals recurrent versus divergent profiles in acute myeloid leukemia with recurrent genetic abnormalities - T. Ferrari, G. Tsilimidos, O. Naveiras, B. Deplancke
  9. A Digital Learning Ecosystem Improves Access to Structured Postgraduate Education in Academic Haematology and Oncology - N. Karantzelis, T. M. Benoit, M. Liu, R. Schwotzer, A. Wicki, M. G. Manz
  10. Do SSH-SSMO/SOHC Abstracts Make It to Print? Publication and Authorship Outcomes - S. Mikula, D. Taussky, D. Benzaquen, A. Champion, A. Sabbah
  11. Safety and Tolerability of Bispecific Antibody Therapies Versus CAR-T Cell Therapy: A Systematic Review and Meta-Analysis - M. M. Bilal, A. Hizomi, S. K. Ayaanuddin
  12. Efficacy and Safety of Venetoclax-Based Therapy Versus Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis - M. M. Bilal, S. K. Ayaanuddin, A. Hizomi
  13. Treatment choice in chronic lymphocytic leukaemia (CLL): physician and patient preferences in Switzerland - S. Müller, D. Feltrin, N. Heim, B. Peschke

Poster only (without presentation)

  1. Clinical evaluation of an HCT-specific evidence-linked reasoning system in allogeneic stem cell transplantation - H. Boyadzhiev, J. Lötscher, D. Ditz, C. Meloni, E. Heilmann, D. Pfingst, E. Antonopoulou, J. Passweg, J. Halter, P. Schlaepfer, D. Hauzenberger, J. Paschke, J. Kopec, S. Staiger, C. C. Widmer
  2. A clinical case of neoehrlichiosis mimicking a lymphoma relapse in a b-cell-depleted patient - A. Sturm, J. Sumer, T. Lehmann
  3. When Two Rarities Collide: Hepatic Monoclonal Immunoglobulin Deposition Disease as the First Manifestation of IgG4 Multiple Myeloma - M. Costanza, B. Bisig, A. Cairoli
  4. Donor-Derived TP53 Clonal Hematopoiesis after Haploidentical Transplantation for DDX41-Mutated AML: A Case Report - E. Antonopoulou, E. Georgieva, A. Stelmes, M. Bader, D. Juskevicius, F. Matteazzi, J. Tossounidis, P. Apostolova, J. Passweg, J. Halter, B. Drexler
  5. Late diagnosis of WHIM syndrome: an odyssey and a novel targeted treatment - M. Recher
  6. KMT2A Amplification on Two Distinct Ring Chromosomes in Mixed Phenotype Acute Leukemia: A rare Cytogenetic Constellation - E. Wilhelm, B. Okamura, B. Glaeser, M. Stoikou, J. Dirks, S. Dirnhofer, T. Junker, A. Stelmes
  7. Belumosudil for chronic graft-versus-host disease: a case report with excellent response - E. Georgieva, G. Nair, S. Werner, M. Fricker, P. Charitos-Fragkakis, A. Stelmes, R. Mathew, B. Drexler, J. Halter
  8. BCR::ABL1-Positive Megakaryoblastic Leukemia: When AML and CML Blasts Become Indistinguishable - R. Latscha, D. Ditz, J. Dirks, B. Kopp, A. Handschin, A. Tzankov, T. Menter, C. Widmer
  9. Tracheal Involvement in Chronic Lymphocytic Leukemia: A Case Report - D. Heim, L. Stutz, P. Konermann, T. Menter, J. R. Passweg, M. Pradella, A. Holbro, L. Stutz
  10. Diagnostic Uncertainty and Transfusion Independence With Momelotinib in a Myeloid Disorder Without a Detectable Clonal Marker - L. J. Drück, M. M. Bühler, S. Gundermann
  11. Simultaneous presence of t(5;9) and t(9;14) in a patient with B-lineage acute lymphoblastic leukemia :case report and literature review - J. T. Liu, H. R. Li, L. Jiang, P. Zhang

Guided Poster Tour Station 3 - Experimental hematology / oncology

Chair: Petya Apostolova (Basel), Thibaud Kössler (Geneva)

  1. Tissue-specific partial reprogramming in the aged hematopoietic compartment - A. Alonso Calleja, A. Jimenez Sanchez, C. Bataclan, F. Schyrr, S. Ferreira Lopes, T. Smirnova, K. Kioseoglou, M. C. Galavotti, G. Desdín-Mico, O. Naveiras
  2. The CD19 CAR T Hinge Region Influences Avidity and Cytotoxicity in CD19 SNP Variants in B-cell Lymphoma - L. Hörtensteiner, H. Mandhair, S. Fischer, K. Seipel, F. S. Krebs, V. Zoete, U. Novak, T. Pabst, M. Wehrli
  3. T cell receptor repertoire architecture and benefit from immune checkpoint inhibition - C. Schultheiss, L. Braun, P. Schmidt-Barbo, M. Kalweit, A. Stein, R. Zeiser, M. Binder
  4. Combined heterozygous RAG1/RAG2 mutations are linked to immunodeficiency and loss of tolerance - A. J. Jauch, O. Bignucolo, M. Bosticardo, F. Pala, O. Delmonte, M. Dölz, M. Ghraichy, B. Meyer, R. Higgins, A. Ghosh, I. Heijnen, J. Dirks, V. von Niederhäusern, F. Baldin, F. Maquardsen, U. Boglarka, K. Csomos, M. Talib, J. Trück, L. Jörg, A. MacPherson, J. R. Passweg, J. Halter, W. V. Bonilla, K. S. Lang, C. T. Berger, A. Navarini, A. Oxenius, C. Hess, J. E. Walter, L. D. Notarangelo, M. Recher
  5. ASPP2κ uncouples PD-L1 expression from interferon-driven T cell recruitment in triple-negative breast cancer - a candidate mechanism of primary checkpoint resistance - K. M. Kampa-Schittenhelm, C. Wincek, A. Ruiba, W. Liu, K. Jahankhani, S. Kembu Chettiar Ravichandran, B. Ludewig, W. Jochum, M. M. Schittenhelm
  6. Modulating the bone marrow adipocytes differentiation axis to target measurable residual disease in pediatric and young adult T-ALL - C. Bataclan, A. Martins, R. Benhassine, U. Koch, F. Radtke, S. Ferreira Lopes, T. Smirnova, O. Naveiras
  7. Hematon Units from liquid biopsies enable robust 3D imaging of human bone marrow niche heterogeneity - Y. Zhang, R. Sarkis, C. Bataclan, L. Angenendt, V. Basset, T. Smirnova, E. Boeri, N. Piazzon, D. Maison, M. Constanza, N. Dewarrat, S. Cherix, O. Spertini, S. Blum, B. Deplancke, L. de Leval, T. Schroeder, O. Naveiras
  8. Scalable single-cell Functional Precision Medicine via AI-driven morphological profiling across hematological and solid tumors - B. D. Hale, R. Wegmann, M. Wyss, P. Hanns, R. Lima, M. Nunez, V. Heinzelmann-Schwarz, B. Snijder, F. Jacob, Y. Severin
  9. Decoding Cell Fate: Autophagy-Apoptosis Crosstalk in Pediatric Immune Thrombocytopenia - C. Bitsina, T. Stein, M. Seiler, A. Balduini, C. di Buduo, M. Schmugge, F. D. Franzoso
  10. Tumour-restricted IL-2 delivery via an immunocytokine enhances CAR T-cell efficacy in solid tumour models - C. Pellegrino, C. F. Magnani

Poster only (without presentation)

  1. Acute Myeloid Leukemia Microenvironment: Targeting the Bone Marrow Adipocyte Differentiation Axis as a Novel Strategy to Reduce AML Progression - T. Smirnova, C. Bataclan, A. Martins, R. Sarkis, G. Tsilimidos, S. Blum, C. Mariangela, L. De Leval, O. Naveiras
  2. ProFeaTrOL, a bioinformatic tool to help interpreting the pathogenicity of germline missense single nucleotide variants of BAP1 - P. Marchal, J. Spies, L. Bürgi, K. Samarasinghe, L. Lane, F. Cerciello
  3. ULK1 complex inhibition restores MHC-I expression in Diffuse Large B-cell lymphomas - H. Mandhair, J. Dengjal, C. Kosnopfel, G. Lenz, A. Davies, M. P. Tschan, U. Novak
  4. A Spatial Protemics Map of Novel ADC and BiTE Targets Across Longitudinal Colorectal Cancer Cohorts - C. Bothou, B. Ehret, A. Eklund, A. Burrus, J. Schneider, E. Danenberg, M. Daniel, S. Haefliger, N. Miglino, G. Gut, B. Gosztonyi, D. Rutishauser, M. D. Brada, S. Dettwiler, M. Cieri, S. de Zanet, A. Spinelli, S. Piscuoglio, A. Jacobs, J. R. Fischer, S. Chevrier, H. Moch, A. Wicki, B. Bodenmiller
  5. Assessing Growth Modulation Index as marker for clinical activity in a Phase 1 study with a next generation BRAF inhibitor - N. H. Bischoff, D. Dejardin, N. Keshelava, A. Roller, G. Schnetzler
  6. Aged Hematopoietic Stem Cells Enhance Immunotherapy Response in a Young Host - I. Delle Fontane, H. Carrasco Hope, C. Caballero Cifuentes, M. Morbidelli, V. Núñez Quintela, M. Naderi, L. Chentout, N. Vannini

Guided Poster Tour Station 4 - Clinical solid tumor oncology

Chairs: Isabel Stiefel (Zurich), Eugenio Fernandez (Geneva)

  1. Multimodal AI Recurrence Risk Stratification Is Maintained in Patients Aged ≥70 Years With Breast Cancer - E. D. Chiru, L. Sojak, S. Muenst, J. Witowski, K. Zeng, C. Tang, C. Kurzeder, M. Vetter
  2. Obesity Paradox on Oncological Outcomes in Patients Treated with Robotic Stereotactic Body Radiotherapy for Primary Prostate Cancer - M. Elleisy, N. Bachmann, S. Oberhansl, A. Althaus, L. Mose, D. Aebersold, M. Shelan
  3. Avelumab first-line maintenance for locally advanced or metastatic urothelial carcinoma in Europe and Russia: Interim results from the AVENUE study - D. Zihler, A. Sultanbaev, A. L. Brachtel, M. Z. Poves, S. Rausch, K. Schlack, S. Hoch, S. Banek, A. García Domínguez, I. González, N. Lainez, U. Anido, G. Niegisch, A. Kohler, A. M. Diaz, S. Bhunia, T. Hack, J. Hoffman, P. J. Goebell, J. E. Gschwend
  4. Beyond Chronological Age: Real-World Association Between Age and G8 Screening Scores in Older Adults With Cancer - E. D. Chiru, D. Hašek, D. Wirth, C. Müller, H. Unger, T. Wallrabenstein, M. Sonderegger, M. Vetter
  5. Patient reported long term functional outcome after treatment of localized rectal cancer: a cross-sectional study (PROCRESS) - J. Gorges, T. Jumuga, S. Bastian, R. Cathomas
  6. Oncogene-Driven Genomic Profiles are Linked to Poor Overall Survival in Muscle-Invasive Bladder Cancer (MIBC) - C. Poyet, A. S. Franzen, U. Bieri, E. Kaufmann, D. Eberli, M. Schmid, M. Zoche, H. Moch, M. Lork
  7. Real-World Prevalence of HER2 IHC 3+ in Unselected NSCLC: Implications for Testing Strategy. - M. Lipp, L. Boos, O. Chijioke, C. Pauli, M. Haberecker
  8. Investigating Pemetrexed's Role in Maintenance Therapy for Metastatic Non-Squamous NSCLC After Platinum-Based Chemo-Immunotherapy with Pembrolizumab - L. A. Boos M. Sarwary, L. Hempel, N. Miglino, L. Fábregas-Ibáñez, A. Wicki

Poster only (without presentation)

  1. Clinical Outcomes in Patients with BRCA2-Altered mHSPC Treated with Niraparib Plus Abiraterone and Prednisone: AMPLITUDE Subgroup Analysis - A. Omlin, D. E. Rathkopf, N. Agarwal, J. N. Graff, S. Sandhu, E. Efstathiou, M. Özgüroğlu, A. J. Pereira de Santana Gomes, K. Vianna, H. Luo, G. T. Gotto, H. H. Cheng, K. S. Gries, B. Baron, F. Shen, S. D. Mundle, S. A. McCarthy, D. Olmos, K. N. Chi, G. Attard
  2. Comparison of Child–Turcotte–Pugh Score and Albumin–Bilirubin Index for Prognostication in Advanced Hepatocellular Carcinoma: A Five-Year Prospective Cohort Study from a Tertiary Cancer Centre in a Low- and Middle-Income Country - X. Sinha
  3. Exploring Microbial and Metabolic Signatures in Non-Muscle-Invasive Bladder Cancer: A Pilot Study - M. Lork, Y. Morsy, J. Surber, M. Scharl, V. Wu, N. Zamboni, J. H. Rüschhoff, A. Ebner, D. S. Engeler, B. Förster, L. J. Hefermehl, J. Langenauer, F. Obrecht, R. Seiler-Blarer, D. Eberli, B. Kaufmann, C. Poyet, U. Bieri
  4. Early Circulating Tumour DNA Dynamics Predict Outcomes After Anti-EGFR Rechallenge in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis - M. M. Bilal, M. S. Patel, S. Firdos, S. Zaidhulla, A. A. Khaleelullah, M. Naveed, A. A. Patel, T. A. Mukadam, D. L. Kotak
  5. Health care costs by treatment pathways in men with localized prostate cancer: a Swiss claims data analysis (2015–2024) - M. Stucki, L. Cakir, A. Omlin, M. Pratsinis, D. Zwahlen, S. Wieser
  6. Synchronous MSI-H Ampullary and Colonic Adenocarcinomas with Concurrent Germline MSH2 and RAD51C Pathogenic Variants in a Young Patient - I. Huber, B. Ramos, R. K. de Lima, F. C. Pelloso, M. E. Consolaro, A. C. Alarcao, M. R. Bitencout, R. K. Cuman, M. D. Carvalho, V. D. Marques, S. M. Pelloso
  7. Evaluation of the effectiveness of radio-oncological therapy concepts in geriatric head and neck cancer patients - M. Bürstner
  8. A Shared BRIP1 Variant in Father–Son Pancreatic Cancer: A Familial Molecular Observation with Potential Implications for Homologous Recombination Repair - N. Degrauwe, G. Dei Tos, M. Trimech, K. Homicsko, A. Digklia
  9. Cisplatin-gemcitabine versus MVAC Regimen as neoadjuvant therapy in Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis - A. Sakh, F. Faza
  10. Heart Rate Variability and Systemic Inflammation as Non-Invasive Biomarkers of Physiological Burden and Resilience in Lung Cancer Patients - L. Hunakova, M. Zvarik, I. Mikolaskova, E. Zurkova
  11. Liver Transplantation (LT) for Colorectal Liver Metastases (CRLM): A Case Report - O. Novosad, P. Majno-Hurst, A. De Gottardi, G. Bedino, A. Cristaudi, P. Compagnon, J. Roggero, A. Pedrazzini, E. Roggero
  12. Bone Marrow Carcinomatosis in Essential Thrombocythemia Revealing Claudin-18.2-Positive Malignancy: From Diagnostic Clues to Biomarker-Guided Therapy - T. Materski, J. Roggero, R. Grobholz, C. Pauli, N. Cantoni, C. Bothou
  13. Targeted therapies in metastatic pancreatic ductal adenocarcinoma and cholangiocarcinoma: a visual comparison of actionable molecular alterations - M. Fivaz, V. Genoud, T. Koessler
  14. RASolve 301: Phase 3 trial in progress of daraxonrasib vs. docetaxel in previously treated RAS mutant non-small cell lung cancer - A. Curioni-Fontecedro, F. Skoulidis, K. C. Arbour, S. Popat, C. R. Lindsay, H. Hironouchi, G. Zalcman, J. Naidoo, A. J. de Langen, L. Tao, E. Su, M. Hiremath, A. Rittmeyer, M. Johnson
  15. Bone Marrow Carcinomatosis with Bicytopenia Mimicking a Haematological Disorder as the Initial Presentation of Metastatic Breast Cancer - B. Okamura, G. Favre, S. Ebner, R. Zanetti, M. Vetter

Guided Poster Tour Station 5 - Nursing, supportive & palliative care, rehabilitation & survivorship and integrative oncology

Chairs: Anna Götz (Zürich), Holger Hass (Mammern)

  1. Structured hypnotherapy during (neo)adjuvant chemotherapy: a randomized controlled study - C. Urech, I. Ge, A. Wiencierz, C. Wenk, C. Mang, A. Oseledchyk, A. Brandt, D. Schäfer-Rohr, A. Kölle, C. Balmelli, L. Basic, F. D. Schwab, C. Montavon, W. P. Weber, V. Heinzelmann, C. Schwegler, C. Kurzeder
  2. Broad in ambition, thin in commitment: what Switzerland's first national cancer plan needs before adoption - S. Schobinger
  3. Emergency Department Visits and Hospitalisations in Older Adults with Cancer: A Retrospective Cohort Study - I. Besser, C. Müller, M. Sonderegger, H. Unger, D. Wirth, N. Geigy, F. Dreyer, M. Vetter
  4. Experiences, satisfaction and patient reported outcomes of cancer patients at a complementary and integrative medicine outpatient service - U. Wolf, J. Ertl, E. Timm, I. Berlowitz, C. Maake
  5. Routine Serial ePROMs Assessment Confirms Subjective Improvement Across All Domains During Ambulatory Oncology Rehabilitation and Predicts Relative Magnitude of Benefit - R. A. Popescu, A. Jakob, A. Gutierez, C. Kolotas, G. Gruber, M. C. Schumacher, G. Popescu, V. Blum, K. Tyriakidis, C. Leuenberger, F. Weber, C. Zobrist, C. Märtz, C. Stein, E. Fiechter, E. Ajrovski, S. Rutz, K. Saba, M. Sumila, K. Brouwer, S. Abbeel, C. von Briel, M. Hickey, J. Lyle
  6. Sleep disorders in breast cancer patients with chronic cancer-related fatigue: more than insomnia? - T. T. Rotar, M. Reif, R. Zerm, F. Strasser, M. Kröz
  7. Use of infusion pumps to administer red blood cell concentrates; A literature review of the current evidence on the use of infusion pumps and their effects compared with administration by gravity. - L. Brunner, S. Schönfeld
  8. Determinants of Self-Efficacy for Symptom Self-Management Among Patients Receiving Cancer Treatment: An Integrative Review - A. Ulahannan, L. Matlet, C. Gremaud, M. De Pretto, M. Eicher
  9. Key Factors and Competencies for High-Quality Palliative Care in Primary Healthcare - M. Brinovec, P. Ovčar

Poster only (without presentation)

  1. Distraction with Virtual Reality and Tablet Devices During Routine Needle Procedures in Children with Cancer: A Protocol for a Randomized Controlled Trial - S. Aljomaa, M. Garami
  2. Liminality – A concept to understand patient life transitions after cancer treatment - T. Mathieu, S. Cairo Notari, N. Favez